According to a recent LinkedIn post from Latent, the company is highlighting its collaboration with St. Luke’s Health System and pharmacy leader Josh Weber around the use of artificial intelligence in prior authorization workflows. The post points to operational outcomes at St. Luke’s, where AI-enabled process changes are described as reducing prior authorization turnaround times from more than seven days to about three days while handling an additional 1,200 cases per month with the same staffing levels.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Latent is positioning its technology as a driver of administrative efficiency in ambulatory, retail, and specialty pharmacy services, with implications for both patient access and revenue growth for provider organizations. For investors, this emphasis on measurable workflow improvements and scalable volume gains may signal product-market fit in the healthcare AI segment and could support Latent’s competitive standing as health systems seek ROI-focused automation solutions.